Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1283-1291

  Spencer, C ^a   Petrovic, I ^a   Fatemi, S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Kaiser Permanente ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BIOTINYLATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY; SENSITIVITY ANALYSIS; THYROID CANCER;

AUTOANTIBODIES; FALSE NEGATIVE REACTIONS; HUMANS; IMMUNOASSAY; LUMINESCENCE; RADIOIMMUNOASSAY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 79955653371     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2762     Document Type: Article

References (42)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
2. Preissner CM,O'Kane DJ, Singh RJ, Morris JC, Grebe SKG 2003 Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88:3069-3074 (Pubitemid 36877474)
3. Giovanella L, Ghelfo A 2007 Undetectable serum thyroglobulin due to negative interference of heterophile antibodies in relapsing thyroid carcinoma. Clin Chem 53:1871-1872 (Pubitemid 47509689)
4. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127 (Pubitemid 28496379)
5. Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, Lee DS, Lee MC, Cho BY 2002 Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 57:215-221 (Pubitemid 34989098)
6. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS 2005 Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 90:5566-5575 (Pubitemid 41415459)
7. Phan HT, Jager PL, van der Wal JE, Sluiter WJ, Plukker JT, Dierckx RA, Wolffenbuttel BH, Links TP 2008 The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) andTgantibodies during ablation. Eur J Endocrinol 158:77-83 (Pubitemid 351211043)
8. Görges R, Maniecki M, Jentzen W, Sheu SN, Mann K, Bockisch A, Janssen OE 2005 Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 153:49-55 (Pubitemid 41030515)
9. Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu JS, Gong G, Hong SJ, Shong YK 2008 Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93:4683-4689
10. Seo JH, Lee SW, Ahn BC, Lee J 2010 Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F-FDG PET/ CT. Clin Endocrinol (Oxf) 72:558-563
11. Verburg FA, Wäschle K, Reiners C, Giovanella L, Lentjes EG 2010 Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. Horm Metab Res 42:736-739
12. Spencer CA, Fatemi S, Singer P, Nicoloff J, Lopresti J 2010 Serum basal thyroglobulin measured by a 2nd generation assay correlates with the recombinant human TSH-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. Thyroid 20:587-595
13. Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW, Son HY 2010 Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20:885-891
14. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126
15. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346-351
16. Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A, Pinchera A 2008 Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab 93:591-596 (Pubitemid 351246677)
17. Tozzoli R, Bizzaro N, Tonutti E, Pradella M, Manoni F, Vilalta D, Bassetti D, Piazza A, Rizzotti P 2002 Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 40:568-573 (Pubitemid 34855122)
18. La'ulu SL, Slev PR, RobertsWL2007 Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays. Clin Chim Acta 376:88-95
19. Krahn J, Dembinski T 2009 Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 42:416-419
20. Benvenga S, Burek CL, Talor M, Rose NR, Trimarchi F 2002 Heterogeneity of the thyroglobulin epitopes associated with circulating thyroid hormone autoantibodies in hashimoto's thyroiditis and non-autoimmune thyroid diseases. J Endocrinol Invest 25:977-982 (Pubitemid 36113283)
21. Madureira D, Prazeres S, Pedro MS, Pereira T, Font AP, Bugalho MJ 2008 In vitro assays to test the interference of anti-thyroglobulin antibodies on thyroglobulin measurement. Endocrine 33:40-44
22. Sapin R, d'Herbomez M, Gasser F, Meyer L, Schlienger JL 2003 Increased sensitivity of a new assay for anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease. Clin Biochem 36:611-616
23. Schneider AB, Pervos R 1978 Radioimmunoassay of human thyroglobulin: the effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 47:126-137 (Pubitemid 8371253)
24. Stanojevic M, Savin S, Cvejic D, Djukic A, Jeremic M, Zivancević, Simonovic S 2009 Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in postsurgical differentiated thyroid carcinoma patients. J Clin Lab Anal 23:341-346
25. Clark PM, Beckett G 2002 Can we measure serum thyroglobulin? Ann Clin Biochem 39:196-202
26. Rosário PW, Maia FF, Fagundes TA, Vasconcelos FP, Cardoso LD, Purisch S 2004 Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance. Arq Bras Endocrinol Metab 48:487-492
27. Pacini F, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E, Pinchera A 1988 Thyroid autoantibodies in thyroid cancer: Incidence and relationship with tumor outcome. Acta Endocrinol 119: 373-380
28. McLachlan SM, Rapoport B 2004 Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies. Thyroid 14:510-520 (Pubitemid 39014589)
29. Thomas D, Liakos V, Vassiliou E, Hatzimarkou F, Tsatsoulis A, Kaldrimides P 2007 Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation. J Endocrinol Invest 30:173-180 (Pubitemid 46929314)
30. Spencer CA, Platler BW, Nicoloff JT 1985 The effect of 125-I thyroglobulin tracer heterogeneity on serum Tg RIA measurement. Clin Chim Acta 153:105-115 (Pubitemid 16206357)
31. Rodbard D 1978 Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays. Anal Biochem 90:1-12 (Pubitemid 9062229)
32. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
33. Adil A, Jafri RA, Waqar A, Abbasi SA, Matiul-Haq, Asghar AH, Jilani A, Naz I 2003 Frequency and clinical importance of anti-Tg auto-antibodies (ATG). J Coll Physicians Surg Pak 13:504-506 (Pubitemid 37279385)
34. Rubio IG, Silva MN, Knobel M, Romão R, Possato R, Gebrin EM, Buchpiguel C, Medeiros-Neto G 2007 Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pretreatment with recombinant human thyrotropin. J Endocrinol Invest 30:535-540 (Pubitemid 47577804)
35. Polyzos SA, Anastasilakis AD 2010 Alterations in serum thyroidrelated constituents after thyroid fine-needle biopsy: a systematic review. Thyroid 20:265-271
36. Haapala AM, Soppi E, Mörsky P, Salmi J, Laine S, Mattila J 1995 Thyroid antibodies in association with thyroid malignancy II: qualitative properties of thyroglobulin antibodies. Scand J Clin Lab Invest 55:317-322
37. Okosieme OE, Evans C, Moss L, Parkes AB, Premawardhana LD, Lazarus JH 2005 Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery. Clin Chem 51:729-734 (Pubitemid 40463924)
38. Magro G, Perissinotto D, Schiappacassi M, Goletz S, Otto A, Müller EC, Bisceglia M, Brown G, Ellis T, Grasso S, Colombatti A, Perris R 2003 Proteomic and postproteomic characterization of keratin sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomas. Am J Pathol 163:183-196 (Pubitemid 36759603)
39. Gao Y, Yuan Z, Yu Y, Lu H 2007 Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay. Clin Biochem 40:735-738 (Pubitemid 46829077)
40. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum thyrotropin, thyroxine, and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab 87:489-499
41. Ericsson UB, Christensen SB, Thorell JI 1985 A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol 37:154-162 (Pubitemid 15239401)
42. Elkon K, Casali P 2008 Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 4:491-498